470 related articles for article (PubMed ID: 28365879)
1. Geoepidemiology and changing mortality in primary biliary cholangitis.
Floreani A; Tanaka A; Bowlus C; Gershwin ME
J Gastroenterol; 2017 Jun; 52(6):655-662. PubMed ID: 28365879
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
3. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
4. Investigational drugs in phase II clinical trials for primary biliary cholangitis.
Silveira MG; Lindor KD
Expert Opin Investig Drugs; 2017 Oct; 26(10):1115-1121. PubMed ID: 28836457
[TBL] [Abstract][Full Text] [Related]
5. Finding the cure for primary biliary cholangitis - Still waiting.
Tanaka A; Gershwin ME
Liver Int; 2017 Apr; 37(4):500-502. PubMed ID: 28371099
[TBL] [Abstract][Full Text] [Related]
6. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
Hirschfield GM; Dyson JK; Alexander GJM; Chapman MH; Collier J; Hübscher S; Patanwala I; Pereira SP; Thain C; Thorburn D; Tiniakos D; Walmsley M; Webster G; Jones DEJ
Gut; 2018 Sep; 67(9):1568-1594. PubMed ID: 29593060
[TBL] [Abstract][Full Text] [Related]
7. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
Bowlus CL; Kenney JT; Rice G; Navarro R
J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
[TBL] [Abstract][Full Text] [Related]
8. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
9. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
10. The challenges of primary biliary cholangitis: What is new and what needs to be done.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
[TBL] [Abstract][Full Text] [Related]
11. Old and new treatments for primary biliary cholangitis.
Chascsa D; Carey EJ; Lindor KD
Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
Yuan Z; Jia G; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
[TBL] [Abstract][Full Text] [Related]
13. Management of primary biliary cholangitis prior to obeticholic acid availability.
Durazzo M; Bonetto S; Fagoonee S; Morgando A; Pellicano R
Minerva Med; 2018 Dec; 109(6):410-417. PubMed ID: 30022645
[TBL] [Abstract][Full Text] [Related]
14. Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.
Harms MH; van Buuren HR; van der Meer AJ
Best Pract Res Clin Gastroenterol; 2018; 34-35():85-94. PubMed ID: 30343714
[TBL] [Abstract][Full Text] [Related]
15. Toward precision medicine in primary biliary cholangitis.
Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF
Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985
[TBL] [Abstract][Full Text] [Related]
16. Current Treatment Options for Primary Biliary Cholangitis.
Wong KA; Bahar R; Liu CH; Bowlus CL
Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
[TBL] [Abstract][Full Text] [Related]
17. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
Aguilar MT; Carey EJ
Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
[TBL] [Abstract][Full Text] [Related]
18. Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid.
Parés A
Dig Dis; 2015; 33 Suppl 2():125-33. PubMed ID: 26642350
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for the treatment of primary biliary cholangitis.
Phaw NA; Dyson JK; Jones D
Expert Opin Emerg Drugs; 2020 Jun; 25(2):101-112. PubMed ID: 32253941
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic advances for primary biliary cholangitis: the old and the new.
Wang L; Zhang FC; Zhang X
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):615-21. PubMed ID: 26862931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
